Le Lézard
Classified in: Business, Covid-19 virus
Subjects: EARNINGS, Conference Call, Webcast

Arcosa, Inc. Announces Second Quarter 2020 Results


Arcosa, Inc. (NYSE: ACA) ("Arcosa," the "Company," "We," or "Our"), a provider of infrastructure-related products and solutions, today announced results for the second quarter ended June 30, 2020 and provided a business update.

Second Quarter Highlights (All comparisons are versus the prior-year quarter unless noted otherwise)

COVID-19 Update

"As we navigate the COVID-19 crisis, our highest priority remains the health and safety of our employees and the communities in which we operate," noted Antonio Carrillo, President and Chief Executive Officer. "I am deeply impressed by the relentless dedication and effort that our Arcosa team demonstrates every day to keep our operations safe as we deliver critical infrastructure products and services. I am also appreciative of the commitment that our employees have shown to our local communities and small businesses, as we work together supporting the path to recovery."

Commenting on second quarter performance, Carrillo said, "Our record second quarter results show the strong fundamentals of our infrastructure-related portfolio, along with excellent execution during the pandemic. All three of our segments delivered year-over-year revenue growth, and Adjusted EBITDA outpaced revenue growth.

"Construction Products generated record EBITDA in the second quarter, as our strategy to grow this segment has shifted our overall portfolio towards a more stable set of end markets, and our operating teams executed well. We produced these strong results even with softness in our shoring and lightweight aggregates business, both of which were negatively impacted by COVID-related slowdowns."

Carrillo continued, "I am also very pleased with our free cash flow generation as we continue to build a ?cash culture' across the company. Strong cash flow and low leverage give us flexibility to continue selectively investing in our growth strategy. Since March, we have invested approximately $60 million to acquire three complementary product lines for our utility structures business. We have added traffic, telecom, and concrete structures at attractive valuations, and we expect these markets to continue growing due to strong infrastructure-related demand in our key regions. Additionally, we expect to achieve growth and cost synergies as we integrate them into our North American footprint.

"Looking forward, the path to sustained economic recovery remains uncertain, and order and inquiry activity during the second quarter was mixed. Demand for utility structures continued to be very healthy and lead times remain extended, and wind tower inquiries are progressing for 2021 production. On the other hand, new orders in barge and rail components were weak, as our customers reduced capital spending in the midst of lower equipment utilization. While construction activity has remained healthy in the first half of the year, we continue to monitor federal and state transportation budgets to determine how the crisis may impact future construction spending."

Carrillo concluded, "We have delivered exceptional results in the first half of 2020, and finished the second quarter with a strong balance sheet and an attractive organic and acquisition pipeline. Although the U.S. economy may be in for an extended period of COVID-related uncertainty, we plan to use this period to continue repositioning our company. In the 18 months since our spin-off, we have made significant progress advancing our long-term vision."

Second Quarter 2020 Results and Commentary

Construction Products

Energy Equipment

Transportation Products

Cash Flow and Liquidity

Non-GAAP Financial Information

This earnings release contains financial measures that have not been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Reconciliations of non-GAAP financial measures to the closest GAAP measure are included in the accompanying tables to this earnings release.

Conference Call Information

A conference call is scheduled for 8:30 a.m. Eastern Time on July 31, 2020 to discuss 2020 second quarter results. To listen to the conference call webcast, please visit the Investor Relations section of Arcosa's website at https://ir.arcosa.com. A slide presentation for this conference call will be posted on the Company's website in advance of the call at https://ir.arcosa.com. The audio conference call number is 888-632-3385 for domestic callers and 785-424-1673 for international callers. The conference ID is ARCOSA and the passcode is 272672. An audio playback will be available through 11:59 p.m. Eastern Time on August 14, 2020, by dialing 800-695-2122 for domestic callers and 402-530-9027 for international callers. A replay of the webcast will be available for one year on Arcosa's website at https://ir.arcosa.com/news-events/events-presentations.

About Arcosa

Arcosa, Inc. (NYSE:ACA), headquartered in Dallas, Texas, is a provider of infrastructure-related products and solutions with leading positions in construction, energy, and transportation markets. Arcosa reports its financial results in three principal business segments: the Construction Products Group, the Energy Equipment Group, and the Transportation Products Group. For more information, visit www.arcosa.com.

Some statements in this release, which are not historical facts, are "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements about Arcosa's estimates, expectations, beliefs, intentions or strategies for the future. Arcosa uses the words "anticipates," "assumes," "believes," "estimates," "expects," "intends," "forecasts," "may," "will," "should," "guidance," "outlook," "strategy," and similar expressions to identify these forward-looking statements. Forward-looking statements speak only as of the date of this release, and Arcosa expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein, except as required by federal securities laws. Forward-looking statements are based on management's current views and assumptions and involve risks and uncertainties that could cause actual results to differ materially from historical experience or our present expectations, including but not limited to assumptions, risks and uncertainties regarding the impact of the COVID-19 pandemic on Arcosa's customer demand for Arcosa's products and services, Arcosa's supply chain, Arcosa's employees ability to work because of COVID-19 related illness, the health and safety of our employees, the effect of governmental regulations imposed in response to the COVID-19 pandemic; assumptions, risks and uncertainties regarding achievement of the expected benefits of Arcosa's spin-off from Trinity; tax treatment of the spin-off; failure to successfully integrate Cherry, or failure to achieve the expected benefits of the acquisition; market conditions and customer demand for Arcosa's business products and services; the cyclical nature of, and seasonal or weather impact on, the industries in which Arcosa competes; competition and other competitive factors; governmental and regulatory factors; changing technologies; availability of growth opportunities; market recovery; ability to improve margins; and Arcosa's ability to execute its long-term strategy, and such forward-looking statements are not guarantees of future performance. For further discussion of such risks and uncertainties, see "Risk Factors" and the "Forward-Looking Statements" section of "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Arcosa's Form 10-K for the year-ended December 31, 2019, Arcosa's Form 10-Q for the quarter-ended March 31, 2020, Arcosa's Form 10-Q for the quarter-ended June 30, 2020 to be filed on or about July 31, 2020, and as may be revised and updated by Arcosa's Quarterly Reports on Form 10-Q and Current Reports on Form 8-K.

Arcosa, Inc.

Condensed Consolidated Statements of Operations

(in millions, except per share amounts)

(unaudited)

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Revenues

$

498.5

 

 

 

$

434.1

 

 

 

$

986.7

 

 

 

$

845.0

 

 

Operating costs:

 

 

 

 

 

 

 

Cost of revenues

396.8

 

 

 

345.7

 

 

 

788.1

 

 

 

678.5

 

 

Selling, general, and administrative expenses

53.9

 

 

 

46.1

 

 

 

105.7

 

 

 

86.9

 

 

 

450.7

 

 

 

391.8

 

 

 

893.8

 

 

 

765.4

 

 

Operating profit

47.8

 

 

 

42.3

 

 

 

92.9

 

 

 

79.6

 

 

 

 

 

 

 

 

 

 

Interest expense

2.8

 

 

 

1.6

 

 

 

6.1

 

 

 

3.5

 

 

Other, net (income) expense

(0.1

)

 

 

(0.1

)

 

 

(0.3

)

 

 

(0.3

)

 

 

2.7

 

 

 

1.5

 

 

 

5.8

 

 

 

3.2

 

 

Income before income taxes

45.1

 

 

 

40.8

 

 

 

87.1

 

 

 

76.4

 

 

Provision for income taxes

11.8

 

 

 

9.0

 

 

 

22.2

 

 

 

16.9

 

 

Net income

$

33.3

 

 

 

$

31.8

 

 

 

$

64.9

 

 

 

$

59.5

 

 

 

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

 

 

Basic

$

0.69

 

 

 

$

0.66

 

 

 

$

1.34

 

 

 

$

1.23

 

 

Diluted

$

0.68

 

 

 

$

0.65

 

 

 

$

1.33

 

 

 

$

1.21

 

 

Weighted average number of shares outstanding:

 

 

 

 

 

 

 

Basic

47.9

 

 

 

47.8

 

 

 

47.9

 

 

 

47.9

 

 

Diluted

48.4

 

 

 

48.3

 

 

 

48.4

 

 

 

48.4

 

 

Arcosa, Inc.

Condensed Segment Data

(in millions)

(unaudited)

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

Revenues:

2020

 

 

2019

 

 

2020

 

 

2019

 

Construction aggregates

$

132.1

 

 

 

$

93.2

 

 

 

$

264.2

 

 

 

$

181.6

 

 

Other

16.1

 

 

 

22.4

 

 

 

33.4

 

 

 

40.0

 

 

Construction Products Group

148.2

 

 

 

115.6

 

 

 

297.6

 

 

 

221.6

 

 

 

 

 

 

 

 

 

 

Wind towers and utility structures

176.9

 

 

 

151.0

 

 

 

353.3

 

 

 

309.6

 

 

Other

45.9

 

 

 

53.3

 

 

 

92.7

 

 

 

103.8

 

 

Energy Equipment Group

222.8

 

 

 

204.3

 

 

 

446.0

 

 

 

413.4

 

 

 

 

 

 

 

 

 

 

Inland barges

107.0

 

 

 

66.1

 

 

 

196.0

 

 

 

115.5

 

 

Steel components

21.2

 

 

 

49.2

 

 

 

49.2

 

 

 

97.3

 

 

Transportation Products Group

128.2

 

 

 

115.3

 

 

 

245.2

 

 

 

212.8

 

 

 

 

 

 

 

 

 

 

Segment Totals before Eliminations

499.2

 

 

 

435.2

 

 

 

988.8

 

 

 

847.8

 

 

Eliminations

(0.7

)

 

 

(1.1

)

 

 

(2.1

)

 

 

(2.8

)

 

Consolidated Total

$

498.5

 

 

 

$

434.1

 

 

 

$

986.7

 

 

 

$

845.0

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

Operating profit (loss):

2020

 

 

2019

 

 

2020

 

 

2019

 

Construction Products Group

$

24.3

 

 

 

$

17.5

 

 

 

$

41.1

 

 

 

$

28.8

 

 

Energy Equipment Group

20.9

 

 

 

25.0

 

 

 

45.8

 

 

 

53.2

 

 

Transportation Products Group

15.9

 

 

 

12.6

 

 

 

30.2

 

 

 

20.9

 

 

Segment Totals before Corporate Expenses

61.1

 

 

 

55.1

 

 

 

117.1

 

 

 

102.9

 

 

Corporate

(13.3

)

 

 

(12.8

)

 

 

(24.2

)

 

 

(23.3

)

 

Consolidated Total

$

47.8

 

 

 

$

42.3

 

 

 

$

92.9

 

 

 

$

79.6

 

 

Backlog:

June 30, 2020

 

June 30, 2019

Energy Equipment Group:

 

 

 

Wind towers and utility structures

$

352.2

 

 

$

517.6

 

Other

$

15.5

 

 

$

45.3

 

Transportation Products Group:

 

 

 

Inland barges

$

258.7

 

 

$

349.7

 

Arcosa, Inc.

Condensed Consolidated Balance Sheets

(in millions)

(unaudited)

 

 

June 30, 2020

 

December 31, 2019

Current assets:

 

 

 

Cash and cash equivalents

$

148.4

 

 

 

$

240.4

 

 

Receivables, net of allowance

217.7

 

 

 

200.0

 

 

Inventories

314.0

 

 

 

283.3

 

 

Other

25.8

 

 

 

33.5

 

 

Total current assets

705.9

 

 

 

757.2

 

 

 

 

 

 

Property, plant, and equipment, net

892.7

 

 

 

816.2

 

 

Goodwill

758.0

 

 

 

621.9

 

 

Intangibles, net

146.0

 

 

 

51.7

 

 

Deferred income taxes

15.4

 

 

 

14.3

 

 

Other assets

42.2

 

 

 

41.2

 

 

 

$

2,560.2

 

 

 

$

2,302.5

 

 

Current liabilities:

 

 

 

Accounts payable

$

108.3

 

 

 

$

90.0

 

 

Accrued liabilities

118.7

 

 

 

119.4

 

 

Advance billings

54.4

 

 

 

70.9

 

 

Current portion of long-term debt

4.5

 

 

 

3.7

 

 

Total current liabilities

285.9

 

 

 

284.0

 

 

 

 

 

 

Debt

252.1

 

 

 

103.6

 

 

Deferred income taxes

99.9

 

 

 

66.4

 

 

Other liabilities

73.2

 

 

 

58.1

 

 

 

711.1

 

 

 

512.1

 

 

 

 

 

 

Stockholders' equity:

 

 

 

Common stock

0.5

 

 

 

0.5

 

 

Capital in excess of par value

1,689.4

 

 

 

1,686.7

 

 

Retained earnings

182.9

 

 

 

122.9

 

 

Accumulated other comprehensive loss

(23.7

)

 

 

(19.7

)

 

Treasury stock

?

 

 

 

?

 

 

 

1,849.1

 

 

 

1,790.4

 

 

 

$

2,560.2

 

 

 

$

2,302.5

 

 

Arcosa, Inc.

Consolidated Statements of Cash Flows

(in millions)

(unaudited)

 

 

Six Months Ended
June 30,

 

2020

 

 

2019

 

Operating activities:

 

 

 

Net income

$

64.9

 

 

 

$

59.5

 

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation, depletion, and amortization

54.7

 

 

 

41.5

 

 

Stock-based compensation expense

8.8

 

 

 

7.1

 

 

Provision for deferred income taxes

2.4

 

 

 

9.3

 

 

Gains on dispositions of property and other assets

(1.8

)

 

 

(1.9

)

 

(Increase) decrease in other assets

(2.1

)

 

 

0.2

 

 

Increase (decrease) in other liabilities

(1.8

)

 

 

2.3

 

 

Other

2.1

 

 

 

(2.8

)

 

Changes in current assets and liabilities:

 

 

 

(Increase) decrease in receivables

12.3

 

 

 

65.3

 

 

(Increase) decrease in inventories

(14.7

)

 

 

(32.2

)

 

(Increase) decrease in other current assets

11.8

 

 

 

4.3

 

 

Increase (decrease) in accounts payable

9.1

 

 

 

(13.5

)

 

Increase (decrease) in advance billings

(26.9

)

 

 

0.9

 

 

Increase (decrease) in accrued liabilities

1.5

 

 

 

1.2

 

 

Net cash provided by operating activities

120.3

 

 

 

141.2

 

 

Investing activities:

 

 

 

Proceeds from dispositions of property and other assets

7.0

 

 

 

2.2

 

 

Capital expenditures

(43.6

)

 

 

(38.9

)

 

Acquisitions, net of cash acquired

(313.9

)

 

 

(22.8

)

 

Net cash required by investing activities

(350.5

)

 

 

(59.5

)

 

Financing activities:

 

 

 

Payments to retire debt

(100.7

)

 

 

(80.7

)

 

Proceeds from issuance of debt

250.3

 

 

 

?

 

 

Shares repurchased

(2.0

)

 

 

(8.0

)

 

Dividends paid to common stockholders

(4.9

)

 

 

(5.0

)

 

Purchase of shares to satisfy employee tax on vested stock

(3.3

)

 

 

(4.1

)

 

Other

(1.2

)

 

 

?

 

 

Net cash provided (required) by financing activities

138.2

 

 

 

(97.8

)

 

Net increase (decrease) in cash and cash equivalents

(92.0

)

 

 

(16.1

)

 

Cash and cash equivalents at beginning of period

240.4

 

 

 

99.4

 

 

Cash and cash equivalents at end of period

$

148.4

 

 

 

$

83.3

 

 

Arcosa, Inc.

Reconciliation of Adjusted EBITDA and Adjusted Net Income

($ in millions)

(unaudited)

"EBITDA" is defined as net income plus interest, taxes, depreciation, depletion, and amortization. We adjust EBITDA for certain items that are not reflective of the normal earnings of our business ("Adjusted EBITDA"). GAAP does not define EBITDA or Adjusted EBITDA and they should not be considered as alternatives to earnings measures defined by GAAP, including net income. We use Adjusted EBITDA to assess the operating performance of our consolidated business, as a metric for incentive-based compensation, as a measure within our lending arrangements, and as a basis for strategic planning and forecasting as we believe that it closely correlates to long-term shareholder value. As a widely used metric by analysts, investors, and competitors in our industry, we believe Adjusted EBITDA also assists investors in comparing a company's performance on a consistent basis without regard to depreciation, depletion, amortization, and other items which can vary significantly depending on many factors. "Adjusted EBITDA Margin" is defined as Adjusted EBITDA divided by Revenues.

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

Revenues

$

498.5

 

 

$

434.1

 

 

$

986.7

 

 

$

845.0

 

 

 

 

 

 

 

 

 

Net income

33.3

 

 

31.8

 

 

64.9

 

 

59.5

 

Add:

 

 

 

 

 

 

 

Interest expense, net

2.7

 

 

1.2

 

 

5.8

 

 

2.8

 

Provision for income taxes

11.8

 

 

9.0

 

 

22.2

 

 

16.9

 

Depreciation, depletion, and amortization expense(1)

27.9

 

 

21.7

 

 

54.7

 

 

41.5

 

EBITDA

75.7

 

 

63.7

 

 

147.6

 

 

120.7

 

Add:

 

 

 

 

 

 

 

Impact of acquisition-related expenses(2)

2.5

 

 

0.2

 

 

4.9

 

 

1.6

 

Impairment charge

0.5

 

 

?

 

 

1.8

 

 

?

 

Other, net (income) expense(3)

?

 

 

0.3

 

 

?

 

 

0.4

 

Adjusted EBITDA

$

78.7

 

 

$

64.2

 

 

$

154.3

 

 

$

122.7

 

Adjusted EBITDA Margin

15.8

%

 

14.8

%

 

15.6

%

 

14.5

%

GAAP does not define "Adjusted Net Income" and it should not be considered as an alternative to earnings measures defined by GAAP, including net income. We use this metric to assess the operating performance of our consolidated business. We adjust net income for certain items that are not reflective of the normal operations of our business to provide investors with what we believe is a more consistent comparison of earnings performance from period to period.

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

Net Income

$

33.3

 

 

$

31.8

 

 

$

64.9

 

 

$

59.5

 

Impact of acquisition-related expenses, net of tax(2)

1.9

 

 

0.2

 

 

3.7

 

 

1.2

 

Impairment charge, net of tax

0.4

 

 

?

 

 

1.4

 

 

?

 

Adjusted Net Income

$

35.6

 

 

$

32.0

 

 

$

70.0

 

 

$

60.7

 

(1) Includes the impact of the fair value markup of acquired long-lived assets.

(2) Expenses associated with acquisitions, including the cost impact of the fair value markup of acquired inventory and other transaction costs.

(3) Included in Other, net (income) expense was the impact of foreign currency exchange transactions of $0.2 million and $0.5 million for the three months ended June 30, 2020 and 2019, respectively, and $0.2 million and $1.0 million for the six months ended June 30, 2020 and 2019, respectively.

Arcosa, Inc.

Reconciliation of Adjusted Segment EBITDA

($ in millions)

(unaudited)

"Segment EBITDA" is defined as segment operating profit plus depreciation, depletion, and amortization. We adjust Segment EBITDA for certain items that are not reflective of the normal earnings of our business ("Adjusted Segment EBITDA"). GAAP does not define Segment EBITDA or Adjusted Segment EBITDA and they should not be considered as alternatives to earnings measures defined by GAAP, including segment operating profit. We use Adjusted Segment EBITDA to assess the operating performance of our businesses, as a metric for incentive-based compensation, and as a basis for strategic planning and forecasting as we believe that it closely correlates to long-term shareholder value. As a widely used metric by analysts, investors, and competitors in our industry we believe Adjusted Segment EBITDA also assists investors in comparing a company's performance on a consistent basis without regard to depreciation, depletion, amortization, and other items, which can vary significantly depending on many factors. "Adjusted Segment EBITDA Margin" is defined as Adjusted Segment EBITDA divided by Revenues.

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

 

2020

 

 

2019

 

2020

 

2019

Construction Products

 

 

 

 

 

 

 

Revenues

$

 

148.2

 

 

$

 

115.6

 

 

$

297.6

 

 

$

221.6

 

 

 

 

 

 

 

 

 

Operating Profit

 

24.3

 

 

 

17.5

 

 

41.1

 

 

28.8

 

Add: Depreciation, depletion, and amortization expense

 

13.9

 

 

 

9.0

 

 

27.7

 

 

17.8

 

Segment EBITDA

 

38.2

 

 

 

26.5

 

 

68.8

 

 

46.6

 

Add: Impact of acquisition-related expenses(1)

 

0.4

 

 

 

?

 

 

1.9

 

 

1.4

 

Adjusted Segment EBITDA

$

 

38.6

 

 

$

 

26.5

 

 

$

70.7

 

 

$

48.0

 

Adjusted Segment EBITDA Margin

 

26.0

%

 

 

22.9

%

 

23.8

%

 

21.7

%

 

 

 

 

 

 

 

 

Energy Equipment

 

 

 

 

 

 

 

Revenues

$

 

222.8

 

 

$

 

204.3

 

 

$

446.0

 

 

$

413.4

 

 

 

 

 

 

 

 

 

Operating Profit

 

20.9

 

 

 

25.0

 

 

45.8

 

 

53.2

 

Add: Depreciation and amortization expense

 

8.1

 

 

 

7.3

 

 

15.5

 

 

14.3

 

Segment EBITDA

 

29.0

 

 

 

32.3

 

 

61.3

 

 

67.5

 

Add: Impact of acquisition-related expenses(1)

 

1.4

 

 

 

?

 

 

1.4

 

 

?

 

Add: Impairment charge

 

?

 

 

 

?

 

 

1.3

 

 

?

 

Adjusted Segment EBITDA

$

 

30.4

 

 

$

 

32.3

 

 

$

64.0

 

 

$

67.5

 

Adjusted Segment EBITDA Margin

 

13.6

%

 

 

15.8

%

 

14.3

%

 

16.3

%

 

 

 

 

 

 

 

 

Transportation Products

 

 

 

 

 

 

 

Revenues

$

 

128.2

 

 

$

 

115.3

 

 

$

245.2

 

 

$

212.8

 

 

 

 

 

 

 

 

 

Operating Profit

 

15.9

 

 

 

12.6

 

 

30.2

 

 

20.9

 

Add: Depreciation and amortization expense

 

4.7

 

 

 

3.9

 

 

9.1

 

 

7.7

 

Segment EBITDA

 

20.6

 

 

 

16.5

 

 

39.3

 

 

28.6

 

Add: Impact of acquisition-related expenses(1)

 

?

 

 

 

0.2

 

 

?

 

 

0.2

 

Add: Impairment charge

 

0.5

 

 

 

?

 

 

0.5

 

 

?

 

Adjusted Segment EBITDA

$

 

21.1

 

 

$

 

16.7

 

 

$

39.8

 

 

$

28.8

 

Adjusted Segment EBITDA Margin

 

16.5

%

 

 

14.5

%

 

16.2

%

 

13.5

%

 

 

 

 

 

 

 

 

Operating Loss - Corporate

$

(13.3

)

 

$

(12.8

)

 

$

(24.2

)

 

$

(23.3

)

Impact of acquisition-related expenses - Corporate(1)

 

0.7

 

 

 

?

 

 

1.6

 

 

?

 

Add: Corporate depreciation expense

 

1.2

 

 

 

1.5

 

 

2.4

 

 

1.7

 

Adjusted EBITDA

$

 

78.7

 

 

$

 

64.2

 

 

$

154.3

 

 

$

122.7

 

(1) Expenses associated with acquisitions, including the cost impact of the fair value markup of acquired inventory and other transaction costs.

Arcosa, Inc.

Reconciliation of Adjusted Diluted EPS, Free Cash Flow, and Net Debt to Adjusted EBITDA

(unaudited)

GAAP does not define "Adjusted Diluted EPS" and it should not be considered as an alternative to earnings measures defined by GAAP, including diluted EPS. We use this metric to assess the operating performance of our consolidated business. We adjust diluted EPS for certain items that are not reflective of the normal operations of our business to provide investors with what we believe is a more consistent comparison of earnings performance from period to period.

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

2019

 

2020

 

2019

 

(in dollars per share)

Diluted EPS

$

0.68

 

 

$

0.65

 

 

$

1.33

 

 

$

1.21

 

Impact of acquisition-related expenses

0.04

 

 

?

 

 

0.08

 

 

0.02

 

Impairment charge

0.01

 

 

?

 

 

0.03

 

 

?

 

Adjusted Diluted EPS

$

0.73

 

 

$

0.65

 

 

$

1.44

 

 

$

1.23

 

GAAP does not define "Free Cash Flow" and it should not be considered as an alternative to cash flow measures defined by GAAP, including cash flow from operating activities. We use this metric to assess the liquidity of our consolidated business. We present this metric for the convenience of investors who use such metrics in their analysis and for shareholders who need to understand the metrics we use to assess performance and monitor our cash and liquidity positions. We define Free Cash Flow as cash provided by operating activities less capital expenditures.

 

Three Months Ended
June 30,

 

Six Months Ended
June 30,

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(in millions)

Cash Provided by Operating Activities

$

78.8

 

 

 

$

16.2

 

 

 

$

120.3

 

 

 

$

141.2

 

 

Capital expenditures

(22.5

)

 

 

(20.9

)

 

 

(43.6

)

 

 

(38.9

)

 

Free Cash Flow

$

56.3

 

 

 

$

(4.7

)

 

 

$

76.7

 

 

 

$

102.3

 

 

GAAP does not define "Net Debt" and it should not be considered as an alternative to cash flow or liquidity measures defined by GAAP. The Company uses Net Debt, which it defines as total debt minus cash and cash equivalents to determine the extent to which the Company's outstanding debt obligations would be satisfied by its cash and cash equivalents on hand. The Company also uses "Net Debt to Adjusted EBITDA", which it defines as Net Debt divided by Adjusted EBITDA for the trailing twelve months as a metric of its current leverage position. We present this metric for the convenience of investors who use such metrics in their analysis and for shareholders who need to understand the metrics we use to assess performance and monitor our cash and liquidity positions.

 

June 30, 2020

 

(in millions)

Total debt

$

256.6

 

Cash and cash equivalents

148.4

 

Net Debt

$

108.2

 

 

 

Adjusted EBITDA (trailing twelve months) (1)

$

290.8

 

Net Debt to Adjusted EBITDA

0.4

 

 

(1) Adjusted EBITDA includes 6 month pro-forma adjustment of $18.5 million for Cherry during Q3-Q4 of 2019, using previously disclosed annualized EBITDA of $37M.

 


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: